Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy | Zendy

Teksin Çırpan | Zendy; Cem Yaşar Sanhal | Zendy; Sait Yücebilgin | Zendy; Serdar Özşener | Zendy

Open Access

Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy

Author(s) -

Teksin Çırpan,

Cem Yaşar Sanhal,

Sait Yücebilgin,

Serdar Özşener

Publication year - 2011

Publication title -

journal of the turkish-german gynecological association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.346

H-Index - 16

eISSN - 1309-0399

pISSN - 1309-0380

DOI - 10.5152/jtgga.2011.29

Subject(s) - placenta percreta , medicine , placenta previa , internal iliac artery , caesarean section , obstetrics , ligation , placenta , hysterectomy , adjuvant therapy , pregnancy , surgery , fetus , chemotherapy , biology , genetics

Placenta percreta is one of the life-threatening conditions in modern obstetrics. The rising caesarean section rate means rising placenta percreta rate. Treatment strategies range from a caesarean hysterectomy to leaving the placenta in situ with or without internal iliac artery ligation/uterine artery embolisation and/or methotrexate therapy. We describe a case of placenta previa percreta which we managed successfully with conservative modalities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research